Muscarinic Receptors and Their Physiological Roles
Muscarinic acetylcholine receptors (mAChRs) are G protein-coupled receptors that mediate the metabotropic actions of acetylcholine throughout the central and peripheral nervous systems, with five distinct subtypes (M1-M5) controlling fundamental neuronal, cardiovascular, and smooth muscle functions 1.
Receptor Subtypes and Distribution
The five muscarinic receptor subtypes have distinct but overlapping distributions:
- M1 receptors: Localized to parasympathetic ganglia and widely distributed in the CNS, particularly involved in cognitive processes 2, 3
- M2 receptors: Found on postganglionic cholinergic nerve terminals where they inhibit acetylcholine release through feedback inhibition; predominant in cardiovascular tissue 2, 4
- M3 receptors: Release acetylcholine causing airway smooth muscle constriction; mediate vasodilation and constriction 2, 4
- M4 receptors: Present in CNS with roles in motor function and potentially anti-nociceptive effects 1, 5
- M5 receptors: Least characterized subtype, involved in dopamine regulation 5
Key Physiological Functions
Respiratory System
Vagal-mediated tone through released acetylcholine at motor nerve endings is responsible for both resting and bronchoconstrictive airway responses 2. Parasympathetic activity represents the dominant reversible component in COPD and asthma, as sympathetic terminals on airway smooth muscle cells are rare or nonexistent 2.
Central Nervous System
Muscarinic receptors modulate:
- Neuronal activity and neurotransmitter release across multiple brain regions 6
- Neuronal plasticity affecting motor, sensory, and cognitive processes 6
- Dopamine signaling, with significant implications for schizophrenia, substance use disorders, and mood disorders 5
Cardiovascular System
M2 receptors are no longer considered the only functional cardiac subtype—M1 and M3 receptors mediate both dilation and constriction in the vasculature 4.
Non-Neuronal (Autocrine) Functions
Muscarinic receptors regulate 7:
- Cell growth and proliferation during embryological development
- Oncogenesis and immune responsiveness
- Release of chemical mediators from epithelial cells causing smooth muscle relaxation
- Keratinocyte function and stem cell development
Clinical Relevance
The lack of subtype-selective ligands has historically limited therapeutic development, but recent advances with knockout mice and selective compounds have identified specific mAChR-regulated pathways as targets for Alzheimer's disease, Parkinson's disease, schizophrenia, pain, obesity, and diabetes 8.
Current Therapeutic Applications
- M3 antagonism (or mixed M2/M3 antagonists): Approved for overactive bladder and COPD 7
- Long-acting muscarinic antagonists (LAMAs) like tiotropium: Approved for asthma in patients ≥12 years, providing significant lung function improvement when added to inhaled corticosteroids 9
- M1 agonists: Under investigation for cognitive disorders 1, 10
Important Caveats
The overlapping distribution of receptor subtypes in many tissues and the historical lack of highly selective ligands have made it challenging to definitively determine individual subtype functions 6. Development of subtype-selective radioligands and robust antibodies remains a critical need 3.